CollPlant Biotechnologies annual gross margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Gross Margin Growth & History (CLGN)
CollPlant Biotechnologies's gross margin was 64.78% for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 64.78% | +280.32 pp |
| 2024 | 2024-12-31 | −215.53% | −297.37 pp |
| 2023 | 2023-12-31 | 81.83% | +115.61 pp |
| 2022 | 2022-12-31 | −33.78% | −120.96 pp |
| 2021 | 2021-12-31 | 87.18% | +36.10 pp |
| 2020 | 2020-12-31 | 51.08% | +32.14 pp |
| 2019 | 2019-12-31 | 18.94% | −47.97 pp |
| 2018 | 2018-12-31 | 66.91% | −22.72 pp |
| 2017 | 2017-12-31 | 89.63% | — |
CollPlant Biotechnologies quarterly gross margin
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −115.26% | −124.37 pp |
| Q2 2023 | 2023-06-30 | 93.96% | +70.36 pp |
| Q2 2022 | 2022-06-30 | 34.85% | −28.34 pp |
| Q2 2021 | 2021-06-30 | 37.92% | — |
| Q2 2020 | 2020-06-30 | 9.11% | — |
| Q2 2019 | 2019-06-30 | 23.60% | — |
| Q2 2018 | 2018-06-30 | 63.19% | — |
CollPlant Biotechnologies gross margin trends
Over the last five reported fiscal years, CollPlant Biotechnologies's gross margin increased from 51.08% to 64.78%, a change of +13.70 percentage points. The latest reported quarter, Q2 2024, shows −115.26%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies filings at SEC.gov ↗